Minimal clinically important difference on the Motor Examination part of MDS-UPDRS-Reference-Cited by-同舟云学术

Minimal clinically important difference on the Motor Examination part of MDS-UPDRS

Published:2015-12 Issue:12 Volume:21 Page:1421-1426
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Horváth Krisztina,Aschermann Zsuzsanna,Ács Péter,Deli Gabriella,Janszky József,Komoly Sámuel,Balázs Éva,Takács Katalin,Karádi Kázmér,Kovács Norbert^ORCID

Funder

Bolyai Scholarship of Hungarian Academy of Sciences

Hungarian Brain Research Program

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference29 articles.

1. Measurement of health status. Ascertaining the minimal clinically important difference;Jaeschke;Control Clin. Trials,1989

2. Determination of minimal clinically important change in early and advanced Parkinson's disease;Hauser;Mov. Disord.,2011

3. The clinically important difference on the unified Parkinson's disease rating scale;Shulman;Arch. Neurol.,2010

4. Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release;Hauser;Parkinsons Dis.,2014

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial);2024-09-06

2. Fecal Microbiota Transplantation for Treatment of Parkinson Disease;JAMA Neurology;2024-09-01

3. The effect of dysautonomia on motor, behavioral and cognitive fluctuations in Parkinson’s disease;2024-08-26

4. Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease;Journal of Neural Transmission;2024-08-19

5. Deep brain stimulation for Parkinson’s disease: systematic review with meta-analysis and trial sequential analysis;BMJ Medicine;2024-08